Tune Therapeutics
Randal Goller has over 25 years of experience in facilities and operations management. In 1994, they began their career as a Distributed Controls System Technician at Johnson Controls. Randal then moved to Apex Bioscience Inc in 1997, where they worked as a Facilities/Validation Engineer. In 1998, they became a Senior Technical Specialist at Serentec Inc, providing contract commissioning and validation services. In 2001, they joined Argos Therapeutics, Inc. (NASDAQ: ARGS) as Director of Facilities. In 2018, they became Associate Director of Facilities and Site Operations at Humacyte. In 2020, they joined GRAIL, Inc. as Associate Director Facilities RTP, providing oversight of the facilities team and managing leasehold improvement projects. Randal is currently Director, Head of Facilities at Tune Therapeutics, beginning in 2022.
Randal Goller obtained a Bachelor of Science (BS) in Industrial Technology from East Carolina University, followed by a Master of Science (MS) in Industrial Technology from the same university. In 2010, they obtained a Certified Facility Manager (CFM) certification from the International Facility Management Assocation (IFMA).
This person is not in any offices
Tune Therapeutics
1 followers
With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine. With deep experience and a passionate commitment to exploration and innovation, Tune is driving through an inflection point in the history of genetic medicine: from targeting a limited range of rare conditions, to addressing thousands of common and complex diseases for which no curative treatment is available.